• Loretta Erhunmwunsee, Victoria L Seewaldt, Timothy R Rebbeck, and Robert A Winn.
• Department of Surgery, City of Hope Comprehensive Cancer Center, 1500 E Duarte Rd, Duarte CA 91010, United States; Department of Population Sciences, City of Hope Comprehensive Cancer Center, Duarte, CA, United States. Electronic address: LorettaE@coh.org.
• J Natl Med Assoc. 2021 Aug 1; 113 (4): 436-439.

AbstractThe COVID-19 pandemic reminds us that African American, Latinx, Indigenous, and poor communities face significant healthcare disparities. Members of these communities have increased exposure to the virus due to higher rates of crowded living conditions and employment in essential occupations. Furthermore, news reports and public health data show that residents of these communities have more comorbidities, utilize hospitals with fewer resources, and experience greater treatment delays, all resulting in higher mortality related to COVID-19. The same social determinants contributing to the inequities seen in COVID-19 drive similar disparities in oncology. Oncologic inequities have long predated the inequities associated with COVID-19 and have led to considerably more deaths. These stark realities demand that we stop merely reporting the impact of adverse social determinants on the health of communities. We must instead target these causes of healthcare disparities. Here, we discuss proposed action items from the 2019 National Cancer Policy Forum workshop entitled "Applying Big Data to Address the Social Determinants of Health in Oncology." These actions are critical first steps to address adverse social determinants and thereby decrease unnecessary deaths in underserved communities.Copyright © 2021 National Medical Association. Published by Elsevier Inc. All rights reserved.

14 keywords...

hide…